
1440PDJIPANG study: Randomized phase III study of pemetrexed/cisplatin (PEM/Cis) versus vinorelbine /cisplatin (VNR/Cis) for completely resected p-stage II-IIIA non-squamous non-small cell lung cancer (Ns-NSCLC): Outcomes based on EGFR mutation status
Tsuboi, M, Kenmotsu, H, Yamanaka, T, Yoshiya, K, Takahashi, T, Ueno, T, Goto, K, Daga, H, Ikeda, N, Sugio, K, Seto, T, Toyooka, S, Date, H, Mitsudomi, T, Okamoto, I, Yokoi, K, Saka, H, Okamoto, H, TakVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz258.001
Date:
October, 2019
Fichier:
PDF, 93 KB
2019